|
|
|
|
Vol. 10, Issue 4, 1163-1178, April 1999

and
*Departments of Cellular and Molecular Pharmacology and of
Biochemistry and Biophysics, University of California San
Francisco, San Francisco, California 94143
| |
ABSTRACT |
|---|
|
|
|---|
Persistent directional movement of neutrophils in shallow chemotactic gradients raises the possibility that cells can increase their sensitivity to the chemotactic signal at the front, relative to the back. Redistribution of chemoattractant receptors to the anterior pole of a polarized neutrophil could impose asymmetric sensitivity by increasing the relative strength of detected signals at the cell's leading edge. Previous experiments have produced contradictory observations with respect to receptor location in moving neutrophils. To visualize a chemoattractant receptor directly during chemotaxis, we expressed a green fluorescent protein (GFP)-tagged receptor for a complement component, C5a, in a leukemia cell line, PLB-985. Differentiated PLB-985 cells, like neutrophils, adhere, spread, and polarize in response to a uniform concentration of chemoattractant, and orient and crawl toward a micropipette containing chemoattractant. Recorded in living cells, fluorescence of the tagged receptor, C5aR-GFP, shows no apparent increase anywhere on the plasma membrane of polarized and moving cells, even at the leading edge. During chemotaxis, however, some cells do exhibit increased amounts of highly folded plasma membrane at the leading edge, as detected by a fluorescent probe for membrane lipids; this is accompanied by an apparent increase of C5aR-GFP fluorescence, which is directly proportional to the accumulation of plasma membrane. Thus neutrophils do not actively concentrate chemoattractant receptors at the leading edge during chemotaxis, although asymmetrical distribution of membrane may enrich receptor number, relative to adjacent cytoplasmic volume, at the anterior pole of some polarized cells. This enrichment could help to maintain persistent migration in a shallow gradient of chemoattractant.
| |
INTRODUCTION |
|---|
|
|
|---|
Chemotaxis, or directed cell movement up a chemical gradient,
plays a central role in the accumulation of leukocytes at sites of
infection and inflammation (Baggiolini, 1998
). This motility is thought
to depend on many cellular functions, including 1) protrusion and
adhesion of the front end, driven by actin assembly; 2) contraction,
probably driven by myosin-based motors, which moves nucleus and bulk
cytoplasm in a forward direction; and 3) deadhesion of the trailing
edge, thought to be partly mediated by the Ca2+-sensitive
enzymes, calcineurin and calpain (Cassimeris and Zigmond, 1990
; Downey,
1994
; Huttenlocher et al., 1997
). These processes are
initiated in a coordinated manner by activation of chemoattractant receptors, members of the G protein-coupled receptor superfamily, located at the cell surface.
Neutrophilic leukocytes (neutrophils) can crawl up a chemotactic
gradient that corresponds to a difference in chemoattractant concentration as low as 1% across the length of the cell (Zigmond, 1977
), indicating that these cells can compare and efficiently amplify
small differences in concentrations of the extracellular stimulus.
Moreover, in a homogeneous solution or in a shallow gradient of
chemoattractant, locomoting neutrophils tend to move persistently in a
given direction, turning only at small angles (Zigmond, 1977
; Zigmond
et al., 1981
). Higher density of chemoattractant receptors
at the leading edge of a polarized neutrophil could account for the
asymmetrically distributed sensitivity underlying the ability to
respond to a shallow gradient (Zigmond et al., 1981
). Such
an asymmetric distribution of receptors would enhance the intensity of
signal detected at the anterior pole of a moving neutrophil, relative
to the rest of its surface. By steepening the apparent chemotactic
gradient across the cell, asymmetrically distributed receptors would
reinforce the cell's polarity and persistent forward motion (Zigmond,
1977
; Zigmond et al., 1981
).
The lack of methods for direct observation of cell-surface proteins on
living, moving neutrophils has led most investigators to rely on
approaches that localize chemoattractant receptors on cells fixed after
random polarization in a uniform concentration of chemoattractant. Such
approaches, including the use of labeled ligands (Sullivan, et
al., 1984
; Walter and Marasco, 1984
, 1987
) or anti-receptor
antibodies (Gray, et al., 1997
), have led investigators to
conclude that chemoattractant receptors are concentrated at the front
(Walter and Marasco, 1984
) or midregion (Sullivan, et al.,
1984
) or are uniformly dispersed over the neutrophil surface (Walter
and Marasco, 1987
; Gray et al., 1997
). These discrepancies reflect different techniques and experimental conditions for localizing receptors, but might also result from fixing the cells at different times after application of the stimulus (Sullivan et al.,
1984
; Walter and Marasco, 1984
). The latter possibility would suggest that receptors may be distributed differently in different stages of
the neutrophil response. Two groups have reported greater amounts of
fluorescently labeled N-formyl-Met-Leu-Phe
(fMLP),1 a chemoattractant ligand, at the front of
living polarized neutrophils, suggesting enrichment of the fMLP
receptor at the leading edge (Schmitt and Bultmann, 1990
; McKay
et al., 1991
). These reports (Schmitt and Bultmann, 1990
;
McKay, et al., 1991
) did not indicate whether the increased
fluorescence resulted from an increased concentration of receptor
molecules per unit area of plasma membrane or from the increased
folding of membranes that is seen (Davis, et al., 1982
;
Cassimeris and Zigmond, 1990
) at the leading edge of motile neutrophils.
To observe receptors directly and in real time during chemotaxis, we
sought to express in neutrophils a receptor linked to a fluorescent
tag, green fluorescent protein (GFP). Neutrophils, however, are
terminally differentiated, short lived in vitro, and refractory to most
methods of transfection. Accordingly, we elected to use a cultured
myeloid leukemia cell line, PLB-985, which can be induced by treatment
with DMSO to differentiate into cells that display histochemical,
morphological, and biochemical features of neutrophils (Tucker et
al., 1987
; Dana et al., 1998
). Here we show that on a
glass coverslip these cells also behave strikingly like neutrophils,
adhering, spreading, orienting, and moving in response to a chemotactic
gradient. Using a retroviral vector, we transduced PLB-985 cells with a
GFP-tagged version of a receptor for C5a (hereafter termed the C5aR), a
component of complement that is well established as a chemoattractant
for neutrophils (Gerard and Gerard, 1991
). This approach allows, for the first time, direct observation of a chemoattractant receptor during
migration of living neutrophils.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials
[125I]-C5a was from New England Nuclear (Boston,
MA). The polyclonal anti-C5aR antibody (Morgan et al.,
1993
), raised against an amino acid sequence (residues 9-29) near the
amino terminus of the human C5aR, was a gift from J.A. Ember and T.E.
Hugli (Scripps, San Diego, CA). The Flag-tagged human C5aR cDNA in
pCDM8 was a gift from C. Gerard (Harvard Medical School, Boston, MA).
CalPhos Maximizer and the GFP fusion vector pEGFP-N3 were from CLONTECH (Palo Alto, CA).
1,1'-Dioctadecyl-3,3,3',3'-tetramethyllindodicarbocyanine perchlorate
(DiD) was from Molecular Probes (Eugene, OR). Texas Red-conjugated goat
anti-rabbit IgG was from Jackson Immunoresearch Laboratories (West
Grove, PA). Monoclonal GFP antibody was from CLONTECH. Vectashield
antifade mounting medium was from Vector Laboratories (Burlingame, CA).
Immersion oil (n = 1.518) was from R.P. Cargille Laboratories
(Cedar Grove, NJ). Photoetched grid coverslips 1916-92525 were from
Bellco Glass (Vineland, NJ). The amphotropic packaging cell line PA317
was from the American Type Culture Collection (Manassas, VA). The
myeloid leukemia cell line PLB-985 was a gift from Arie Abo (Onyx
Pharmaceuticals, Richmond, CA). The
2 packaging cell line and the
pLNCX retroviral vector were gifts from J. Michael Bishop (University
of California San Francisco, San Francisco, CA). Polybrene, human
recombinant complement C5a, and fMLP were from Sigma Chemical (St.
Louis, MO). The carboxy-terminal agonist analogue of C5a,
N-Met-Phe-Lys-ProdCha-Cha-dArg (ChaCha) (Konteatis et
al., 1994
) was a gift from Josh Trueheart (Cadus Pharmaceuticals,
Tarrytown, NY). G-418 was from Grand Island Biological (Grand
Island, NY). All other cell culture reagents were from the Cell Culture
Facility (University of San Francisco, San Francisco, CA).
Cell Culture
HEK293 cells and PA317 cells were grown in DMEM supplemented
with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin G. For
2 cells, calf serum was used. PLB-985 cells were grown in RPMI 1640 supplemented with 25 mM HEPES, 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin G, 50 µg/ml gentamicin and 2.5 µg/ml
fungizone. For differentiation, PLB-985 cells were plated at a density
of 0.1 × 106 cells/ml and grown for 4 d until
they reached a density of ~1. 5 × 106 cells/ml.
Cells (2 ml) were then diluted with 16 ml fresh medium (lacking G-418,
gentamicin, and fungizone), and 2 ml of a 13% stock solution of DMSO
was added to the cell suspension. Cells were propagated for 6 or 7 d without changing the medium. Under these conditions, cells remained
subconfluent, and differentiation was optimal, as determined by
superoxide production (Iiri et al., 1995
). Conditioned
medium was collected from PLB-985 cells plated at a density of 1 × 105 cells/ml and grown for 3 d until they reached a
density of ~8 × 105 cells/ml. Cells were spun down,
and the medium was harvested and filtered though a 0.22-µm filter.
C5aR-GFP
To create a C5aR-GFP fusion protein, the whole C5aR cDNA in pCDM8 was amplified by PCR between a T7 primer and a C5aR cDNA carboxy-terminal primer, 5'-CGCGATACCGGTACCCACTGCCTGGGTCTTCTGGGCCATAGTGTC-3', designed to remove the stop codon and create a KpnI site (underlined bases) for in-frame ligation with the KpnI site of pEGFP-N3, located at the 5'- end of the GFP DNA. The PCR product was cut with HindIII/KpnI and subcloned into the pEGFP-N3 fusion vector also cut with HindIII/KpnI. A HindIII/FseI fragment of the PCR-generated product was replaced by a HindIII/FseI fragment from the original C5aR cDNA in pCDM8 to circumvent possible mutations in the receptor sequence introduced by PCR. The final ligated product was sequenced though the remaining region generated by PCR.
Generation of Amphotropic Retroviruses
A retroviral approach was used to create a stable population of
PLB-985 cells expressing GFP or C5aR-GFP. The C5aR-GFP and GFP DNAs
were subcloned into the pLNCX retroviral vector (Miller and Rosman,
1989
) under the control of the cytomegalovirus promoter. The retroviral
plasmids were transfected into
2 ecotropic packaging cells by
calcium/phosphate precipitation. Transiently produced virus was
harvested after 48 h and used to transduce amphotropic PA317
packaging cells. Infections were carried out in 8 µg/ml polybrene for
4 h, infected medium was then diluted 1:1 with fresh PA317 culture
medium, and cells were incubated an additional 48 h. Transduced
PA317 cells were then selected in 0.5 mg/ml of active G-418. After
8-10 d, stable populations of G-418-resistant PA317 cells were established.
Transduction of PLB-985 Cells
PLB-985 cells were cocultured with retrovirally expressing PA317 cells and 8 µg/ml polybrene for 24 h, removed from the PA317 cell monolayer, and plated for 4 h on a new 100-mm culture dish, to separate the PLB-985 cells, which remain in suspension, from contaminating PA317 cells, which adhere to the dish. Transduced PLB-985 cells were selected by incubating an initial concentration of 1 × 105 cells/ml in conditioned medium containing 1.0 mg/ml G-418. Cell medium was changed every other week until confluency was reached (~1.5 × 106 cells/ml). Homogeneous populations of GFP- or GFP-C5aR-positive cells were obtained by fluorescence-activated cell sorting (FACS).
Chemotaxis Assays
HEK293 clones expressing the C5aR and C5aR-GFP were generated
as described (Neptune and Bourne, 1997
). Chemotaxis assays using these
cells were performed in 48-well Boyden chambers as described (Neptune
and Bourne, 1997
).
Binding Assays
PLB-985 cells (2 × 105 cells) were incubated at 4°C for 5 h with various concentrations of [125I]-C5a (400 Ci/mmol, 0.06-3.6 nM) in 200 µl binding buffer containing HBSS, 25 mM HEPES pH 7.4 and 0.1% (wt/vol) bovine serum albumin. Nonspecific binding was defined as the radioactivity bound in the presence of 100 nM nonradioactive C5a. Incubations were terminated by vacuum filtration though presoaked GF/C glass fiber filters (Whatman, Clifton, NJ), followed by rapid washing with 6 ml of ice-cold binding buffer. To determine binding affinities and capacities (Kd and Bmax), binding data were subjected to nonlinear regression analysis using Prism software (GraphPad Software, San Diego, CA).
Microscopy
Differentiated PLB-985 cells were washed once with 10 ml RPMI 1640/25 mM HEPES and resuspended at a concentration of 3 × 106 cells/ml in modified HBSS (mHBSS) containing 150 mM NaCl, 4 mM KCl, 1.2 mM MgCl2, 10 mg/ml glucose, and 20 mM HEPES, pH 7.2. Cells (3 × 105 in 100 µl) were plated on the center of a sterile no. 1.5 coverslip rimmed with a square agarose spacer 10 mm in length and 1 mm in height. The coverslip was incubated in a humid chamber at 37°C with 5% CO2 for 20 min, and nonadherent cells were removed by two washes with mHBSS. Cells were stimulated at room temperature, either uniformly or from a point source of chemoattractant delivered with a micropipette. In the latter case, micropipettes were prepared from a borosilicate capillary with an outer diameter of 1.0 mm and an inner diameter of 0.58 mm using a model P-80/PC Flamming Brown Micropipet Puller (Sutter Instruments, Novato, CA) with step 1: heat = 635; velocity = 20; time = 1; step 2: heat = 605; pull = 160; velocity = 75; time = 25. Under these pulling conditions, the tip of the micropipette is sealed. The micropipette was back-filled with a solution of 10 µM fMLP or 100 µM ChaCha in mHBSS and lowered in focus into the center of the microscope's field of view with a micromanipulator (Narishige USA, Greenvale, NY). The micropipette's tip was broken by touching the side of a broken coverslip. When necessary, air bubbles were pushed out of the micropipette tip by applying a small pressure using a microinjection device. Under these conditions, the broken tip of the micropipette was 0.2 µm or less in diameter and produced more dramatic and more reproducible neutrophil chemotaxis toward the micropipette than did commercially available micropipettes with 0.5-µm tips (Eppendorf Femtotips).
All images were acquired with a scientific-grade cooled charged-coupled
device on a multiwavelength wide-field three-dimensional microscopy
system (Hiraoka et al., 1991
) in which the shutters, filter
wheels, focus movement, and data collection were all computer driven.
Cells were imaged using a 60 × 1.4 N.A. lens (Olympus, Lake
Success, NY) and n = 1.518 immersion oil. Differential
interference contrast images were acquired with a Nomarski
system optimally aligned for our microscope system. For
fluorescence imaging of living cells, the GFP and DiD signals were
acquired in the FITC and Texas Red channels, respectively, on single
optical sections (0.25 µm) near the bottom of cells. These
conditions, at our microscope setting, produce partial confocal images
of the samples (Hiraoka et al., 1990
). For fluorescence
imaging of fixed cells, data stacks of immunofluorescent samples were
acquired in the FITC and Texas Red channels by moving the stage in
successive 0.25-µm focal planes through the sample. Out-of-focus
light was removed with a constrained iterative deconvolution algorithm
(Agard et al., 1989
).
To quantify the relative distribution of receptors within the plasma membrane, DiD and GFP signals were digitally recorded in their respective channels, and total fluorescence intensity of each was determined in five polygons of fixed area, placed at the front and sides of four separate cells. Fluorescence values were divided by the number of pixels, basal fluorescence (based on fluorescence outside the cell) subtracted, and values for the two probes normalized relative to the maximum fluorescence observed in an individual cell for GFP or DiD. Then the ratio of fluorescence intensity of GFP to that of DiD was calculated for each polygon. Mean ± SEM of the ratios for the 20 polygons (4 cells, 5 polygons in each) was calculated.
Immunoblotting
Cells (5 × 106) were lysed in 500 µl SDS sample buffer, and cell extracts were resolved on 8% polyacrylamide gel and transferred onto polyvinylidene difluoride membranes. GFP and C5aR-GFP were detected by immunoblotting with a monoclonal GFP antibody.
Immunostaining of Cell-Surface Receptors
Differentiated PLB-985 cells were plated as already described on
etched grid coverslips, stimulated with a point source of chemoattractant, and fixed for 20 min by flooding with an excess of
3.7% paraformaldehyde in cytoskeleton buffer containing 10 mM HEPES,
pH 7.2, 138 mM KCl, 3 mM MgCl2, 2 mM EGTA, and 0.32 M
sucrose. The location of cells responding to the micropipette was then
recorded on the grid coverslip, which contains 520 alphanumeric coded
squares. Cells were then washed twice in phosphate buffered saline,
incubated for 20 min in a blocking solution (blotto) containing 50 mM
Tris-HCl, pH 7.5, 1 mM CaCl2, and 3% dry milk, followed by
a 45-min incubation with a polyclonal anti-C5aR antibody (5 µg/ml in
blotto). This antibody competes against C5a for binding to its receptor
but not against carboxy-terminal analogues of C5a (Morgan et
al., 1993
). After three successive washes in a solution containing
25 mM Tris-HCl, pH 7.4, 140 mM NaCl, 2.5 mM KCl, and 1 mM
CaCl2, the cells were incubated with Texas Red-conjugated goat anti-rabbit IgG (1:100 dilution in blotto) for 20 min. They were
then washed three times, mounted in Vectashield, and sealed on a slide
with clear nail polish.
Plasma Membrane Labeling with DiD
Differentiated PLB-985 cells were washed as already described. DiD (5 mg/ml in ethanol) was added to the cell suspension (in mHBSS) to a final concentration of 3.3 µg/ml. Cells were thoroughly mixed with the dye, and 3 × 105 cells (in 100 µl) were plated on each glass coverslip. After an incubation of 20 min at 37°C, cells were washed twice with mHBSS and kept in the dark at room temperature until analysis. After long incubations, DiD labels intracellular membranes to some degree (including pinocytotic vesicles). However, we quantified DiD:GFP ratios (see above) only for fluorescent signals at the plasma membrane.
| |
RESULTS |
|---|
|
|
|---|
Responses of PLB-985 Cells to Chemoattractant
Morphological and behavioral responses of differentiated PLB-985
cells to chemoattractant closely resemble those of blood neutrophils.
In the experiment shown in Figure 1, a
micropipette filled with 10 µM fMLP is positioned in front of three
polarized cells. Within 30 sec, cell a shows intense
ruffling at its leading edge (Figure 1A, arrows; a video of the
experiment described in this figure is available on the internet
version of this paper, at http://www.molbiolcell.org). In response to
successive movements of the pipette (Figure 1, B-F), cell a
extends new pseudopodia (arrowheads), reorients, and crawls toward the
pipette. Repositioning the micropipette near cells b and
c (Figure 1, G and H) causes these cells to respond and
extend pseudopodia toward the micropipette, while cell a
continues to follow. Upon removal of the chemoattractant source (Figure
1I), the three cells retract their pseudopodia but keep their polarized
morphology.
|
After differentiation, 50-75% of the PLB-985 cells are unpolarized in the absence of chemoattractant (Figure 1J) but polarize rapidly in response to a pipette containing chemoattractant (Figure 1, K and L). Some cells in the differentiated population, unlike neutrophils, retract their uropods ineffectively, resulting in the formation of long membrane extensions at their back (Figure 1, cell a, panels C-D). In addition, some cells (our unpublished data) show no morphological response to uniform or pipette-delivered chemoattractant; we suspect that such cells are not fully differentiated.
Expression of recombinant genes in PLB-985 cells does not affect the
response to a chemotactic gradient (Figure
2; a video of the experiment described in
this figure is available on the internet version of this paper, at
http://www.molbiolcell.org). Using a retroviral vector, DNA-encoding
GFP was transferred into undifferentiated PLB-985 cells. A population
of transduced cells, selected for resistance to G-418 (see MATERIALS
AND METHODS), was further selected (by FACS) for expression of GFP. GFP
expression in this population is robust but varies significantly from
cell to cell (compare cells b, d, and
e, Figure 2A). In the experiment depicted in Figure 2, five
GFP-expressing cells (previously induced to differentiate by exposure
to DMSO; see MATERIALS AND METHODS) rapidly extend pseudopodia toward
the micropipette delivering fMLP (Figure 2B, arrowheads) and crawl
toward it until they meet in the center of the field (Figure 2, C-F).
|
A Functioning C5aR-GFP Chimera Is Expressed at the Cell Surface
To observe the subcellular distribution of a chemoattractant
receptor in living cells, we attached GFP to the carboxy terminus of
the human C5aR. Figure 3 shows that the
C5aR-GFP chimera can mediate chemotaxis in HEK293 cells and is
targeted to the plasma membrane of PLB-985 cells. Because the C5aR is
normally present in neutrophils (Gerard and Gerard, 1991
), we chose to
test the ability of the chimera to mediate chemotaxis in stably
transfected HEK293 cells; the C5aR-GFP and the wild-type C5aR mediate
chemotaxis over the same range of C5a concentrations (Figure 3, A and
B). The C5aR-GFP also supports chemotaxis in stably transfected avian DT-40 pre-B cells (our unpublished data). In PLB-985 cells,
immunoblots with anti-GFP antibody show a major 70-kDa
band, the size expected for the C5aR-GFP chimera (Figure 3B, lanes 2 and 3). Anti-GFP antibody does not reveal smaller proteins
corresponding to the size of free GFP (27 kDa) (Figure 3B).
|
The C5aR-GFP chimera is expressed on the plasma membrane of PLB-985
cells. Using a retroviral vector, the gene encoding C5aR-GFP was
transferred into nondifferentiated PLB-985 cells. Transduced cells were
then selected and GFP-positive cells sorted by FACS (see MATERIALS AND
METHODS). As expected for a membrane-bound protein, the C5aR-GFP
fluorescent signal in differentiated cells is enriched at the cell
periphery (Figure 4, A and A').
Saturation-binding experiments performed with [125I]-C5a
reveal that expression of the C5aR-GFP chimera increased maximal
binding of C5a at the cell surface by ~60%, relative to cells
expressing the endogenous C5aR (Figure 3C): Kd
and Bmax values (mean ± SD of 3 determinations) were
0.51 ± 0.06 nM and 63,900 ± 7500 sites/cell for
C5aR-GFP-expressing cells, and 0.57 ± 0.23 nM and 40,900 ± 6100 sites/cell for cells expressing GFP alone (not fused to the C5aR).
Both Bmax values are within the range previously reported
for the C5aR of neutrophils (Huey and Hugli, 1985
; Drapeau et
al., 1993
). Fluorescence intensities of individual cells, however,
vary by as much as 10-fold, as determined by FACScan analysis (our
unpublished data). Thus the number of C5aR-GFP molecules in the
PLB-985 cells we examined ranges from ~8000 to ~80,000 per cell.
Nonetheless, the cell-surface location of the C5aR-GFP protein on
moving PLB-985 cells does not depend on the level of its expression
(see Figure 5, compare cells a and d).
|
|
Distribution of the C5aR-GFP in PLB-985 Cells
Exposure of PLB-985 cells to a uniform concentration of C5a causes
agonist-induced internalization of a portion of some C5aR-GFP molecules, but the distribution of receptors at the cell surface remains uniform even when the cells polarize in response to the chemoattractant. In the experiment summarized in Figure 4, receptor distribution in five cells is recorded in living cells under
pseudoconfocal conditions (Hiraoka et al., 1990
) (a video of
the experiment described in this figure is available on the internet
version of this paper, at http://www.molbiolcell.org). Within 56 s
of C5a treatment, clusters of C5aR-GFP begin to form at the plasma
membrane (Figure 4, C and C', arrows). Later time points (Figure 4, D
and E) reveal considerable internalization of C5aR-GFP, in addition to
a dramatic change in cell morphology. Cells increase in size, owing to
agonist-induced spreading and increased adhesion on the glass coverslip
(Figure 4, D and E). After exposure to C5a for 3 min, four of the five cells clearly exhibit front-tail polarity, and internalized receptors are concentrated in their uropods (Figure 4, F and F', arrowheads). C5aR-GFP remaining at the cell surface, however, remains uniformly distributed through the plasma membrane, qualitatively (Figure 4, F and
F') and as indicated by a scan of fluorescence intensity (Figure 4G).
Expression of the C5aR-GFP does not impair the ability of PLB-985
cells to respond to chemoattractant (Figure 5; a video of the
experiment described in this figure is available on the internet version of this paper, at http://www.molbiolcell.org). In this experiment, visualized under pseudoconfocal conditions, cells orient
and move toward a point source of a C5aR agonist, ChaCha (Konteatis
et al., 1994
), delivered by micropipette. Their behavior mimics in detail that described for neutrophils under similar circumstances (Zigmond, 1974
; Gerisch and Keller, 1981
). The
micropipette is first positioned in the middle of a field containing
five cells (Figure 5A). Within 44-110 s, all cells in the field show
clear responses to the ChaCha gradient (Figure 5, B and C). Cell
a, which was already polarized toward the center of the cell
cluster before stimulation (Figure 5A), now exhibits extensive ruffling at its front; cells c and d are clearly polarized
and also exhibit ruffling at their fronts (Figure 5B, arrowheads). The
back of cell b, characterized by its retraction fibers
(Figure 5A, filled arrowhead), transforms into a new leading edge that
moves toward the micropipette, while cell e turns its front
toward the micropipette (Figure 5B). At later time points, all cells in
the field converge and crawl toward the micropipette (Figure 5, D-F);
additional cells, not in the field at the beginning of the experiment,
also make their way up the ChaCha gradient (Figure 5D).
Figure 5 also shows that C5aR-GFP fluorescence remains uniformly distributed on the surface of cells orienting and moving toward the ChaCha-containing micropipette, just as in the case of cells exposed to a uniform concentration of chemoattractant (see Figure 4). The agonist delivered by micropipette also induces accumulation of internalized C5aR-GFP in the uropods of polarized cells (Figure 5F, red arrowheads) within a time scale similar to that seen in uniformly stimulated cells (Figure 4). Nonetheless, most cells show no relative increase of fluorescence intensity anywhere on the cell surface, not even at the leading edge. Trailing portions of certain cells show an apparent decrease in fluorescent signal (Figure 5, C and E, arrows), but focusing up and down showed that this appearance reflects a difference in cell shape at the trailing edge, where the cell flattens and terminates in retraction fibers (see Figure 1A, cells a and b). Consequently, focusing on the front and midregion of cells causes a loss of fluorescence intensity at the back.
C5aR-GFP Fluorescence Is Proportional to Membrane Surface
By itself, the C5aR-GFP fluorescent signal may
not reflect with precision the density of receptor molecules per unit
area of plasma membrane. For example, we sometimes observed an apparent enrichment of C5aR-GFP fluorescence at the anterior poles of moving cells (see Figure 5C, cells b and c), and
therefore asked whether this resulted from an increased density of
receptors or from an increased amount of plasma membrane, which might
be folded more extensively at a cell's leading edge. The experiments
shown in Figures 6 and
7 indicate that the latter explanation is
correct.
|
|
In the three cells shown in Figure 6, each stimulated by a point source of ChaCha, plasma membranes are labeled with a membrane probe, DiD. C5aR-GFP and DiD signals are alternatively recorded, in the FITC and Texas Red channels, respectively. The cells in panels A and C crawl toward the micropipette (shown by the white dot) while the cell in panel B polarizes toward it. At this magnification it is possible to appreciate the complexity of the fluorescent signal at the leading edge (Figure 6, arrows), which reflects ruffles or folds of the plasma membrane caused by dramatic reorganization of the actin cytoskeleton beneath it (Weiner, Servant, Sedat, and Bourne, manuscript in preparation). Under these conditions, the cell in panel A and (to a lesser extent) cells in panels B and C exhibit greater C5aR-GFP fluorescence at their anterior poles where the membrane folds are more complex. DiD fluorescence is also higher at the anterior poles of the cells; indeed, distributions of the C5aR-GFP and DiD signals are superimposable. We infer that the apparent increases in C5aR-GFP concentration reflect increases in relative abundance of plasma membranes, rather than preferential accumulation of receptors, at the leading edge. Quantification of the GFP and DiD signals in 20 patches of membrane (see MATERIALS AND METHODS) revealed a ratio of fluorescence intensities for the two probes (GFP:DiD) of 1.08 ± 0.05 (mean ± SEM of 20 determinations performed in 4 separate cells migrating toward chemoattractant). This ratio does not differ significantly from 1.0; we cannot, however, rule out a very small change (< 8%) in receptor distribution.
To test this inference more stringently, we examined C5aR-GFP and DiD
distribution in a different way (Figure 7). In this experiment, the
C5aR-GFP and DiD signals are acquired on a fixed cell in successive
0.25-µm focal planes through the sample, and out-of-focus light is
removed with a constrained iterative deconvolution algorithm (Agard
et al., 1989
). Maximum intensity projections of all the
three-dimensional data stacks from a polarized cell clearly show
membrane enrichment and concomitant enrichment of receptor density at
the leading edge (Figure 7A, arrow). Figure 7B shows a single focal
plane of the cell in panel A. Once again, the leading edge shows
parallel enrichment of DiD and C5aR-GFP fluorescence in a pattern that
suggests the existence of complex folds even within a thin section.
Together these results indicate that asymmetric distribution of plasma
membrane folds can alter the apparent distribution of a membrane
protein detected by fluorescence microscopy, which has been extensively
utilized to localize chemoattractant receptors on leukocytes (Schmitt
and Bultmann, 1990
; McKay et al., 1991
; Nieto et
al., 1997
). The results also point to a potential limitation of
confocal microscopy: apparent enrichment of a protein may reflect tight
folds of the plasma membrane, rather than changes in concentration of
the protein per square micron of membrane.
Receptors Accessible to the Ligand Are Also Uniformly Distributed
The experiment shown in Figure 8
rules out an alternative mechanism that neutrophils might use to
amplify a chemotactic gradient. In this hypothetical mechanism,
intensity of the extracellular signal is increased at the front because
receptors at the back of the cell are sequestered in a compartment not
accessible to ligand, but located just under the plasma membrane; if
so, C5aR-GFP would appear uniformly distributed, even though a larger
fraction of the receptors at the front of the cell would be able to
detect the chemoattractant. To test the hypothesis,
C5aR-GFP-expressing cells are stimulated with a point source of ChaCha
and fixed, and receptors are assessed both by the C5aR-GFP fluorescent
signal and with an antibody raised against a peptide corresponding to the extracellular amino terminus of the C5aR (Morgan et al.,
1993
). Because this antibody does not compete against C5a analogues for binding to the C5aR (Morgan et al., 1993
), it is possible to
localize cell surface receptors after stimulation with ChaCha. Figure 8 shows a C5aR-GFP-expressing cell fixed while crawling toward ChaCha, delivered by a micropipette (the arrowhead indicates the direction of
migration). Neither the fluorescence specific for the anti-C5aR antibody nor that emitted by C5aR-GFP is enriched at the surface of
the cell's leading edge, compared with the back. The C5aR-GFP and the
antibody signals overlap, with the exception of the intracellular pool
of internalized C5aR-GFP (overlay, arrows).
|
| |
DISCUSSION |
|---|
|
|
|---|
Many investigators have sought to identify and dissect
the working parts of the sophisticated guiding system that neutrophils use to find bacteria at sites of infection (Devreotes and Zigmond, 1988
; Downey, 1994
; Perez, 1994
; Bokoch, 1995
; Prossnitz and Ye, 1997
).
Two kinds of observations suggest that this system depends, in part,
upon relatively enhanced sensitivity to chemoattractant of the crawling
neutrophil's leading edge. First, such cells tend to preserve the same
leading edge, often preferring
like cell e in Figure 5,
above
to turn toward an incoming new chemotactic gradient rather than
to form a new front (Zigmond, 1977
; Zigmond et al., 1981
).
Second, neutrophils crawl up a very shallow gradient with little
apparent deviation from a straight course, even when the concentration
of chemoattractant at the leading edge is only 1% greater than that at
the cell's trailing edge. Together, these findings indicate that
asymmetric sensitivity of the guidance system itself accompanies the
polarized morphology of a neutrophil. An attractive explanation
(Zigmond, et al., 1981
; Cassimeris and Zigmond, 1990
) for
increased sensitivity and persistence of the neutrophil's leading edge
is that the chemoattractant receptors themselves accumulate at a higher
concentration at the front of the cell. To our knowledge, the present
study is the first to test this hypothesis in living neutrophils
engaged in chemotaxis. Our results, with differentiated PLB-985 cells
expressing a GFP-tagged C5aR, indicate that this hypothesis is not
correct. Instead, our results agree with observations in cells of a
unicellular organism, Dictyostelium discoideum: receptors
for cAMP, a chemoattractant for this organism, maintain an even
distribution throughout the cell surface during chemotaxis toward a
pipette containing cAMP (Xiao et al., 1997
).
Here we discuss the relevance of PLB-985 cells for understanding neutrophil chemotaxis, discrepancies between our findings and previous reports, and potential mechanisms that could explain increased sensitivity of the leading edge to chemoattractant, without invoking differential distribution of receptors.
PLB-985 Cells as a Model for Neutrophil Behavior
The PLB-985 cell line was established from cells in the peripheral
blood of a patient with acute nonlymphocytic leukemia (Tucker et
al., 1987
). Growth of these cells in the presence of DMSO induces granulocytic maturation, indicated by morphology, histochemical staining, production of superoxide anions, and increased synthesis of
the primary granule proteinases, elastase and cathepsin G (Dana et al., 1998
). PLB-985 cells differentiated in the presence
of DMSO provide an accurate model for studying neutrophil chemotaxis, as indicated by the following evidence: first, such cells behave like
neutrophils when challenged with either a uniform concentration or a
gradient of chemoattractant (Figures 1, 2, 4, and 5). Exposed to a
uniform concentration of chemoattractant, PLB-985 cells adhere and
spread on glass coverslips; some cells then polarize in random directions, much like neutrophils (Davis, et al., 1982
;
Sullivan, et al., 1984
; Walter and Marasco, 1984
; Cassimeris
and Zigmond, 1990
; McKay et al., 1991
; Gray et
al., 1997
). In contrast
again like neutrophils
differentiated
PLB-985 cells orient themselves toward and then crawl up the gradient
of chemoattractant delivered by micropipette, and retract their
pseudopodia when the source is removed.
Several observations indicate that our fluorescent receptor probe, the
C5aR-GFP protein, accurately reflects behavior of endogenous receptors
for C5a and other chemoattractants on the neutrophil surface. The
fluorescent protein, GFP, has been fused to many proteins, including G
protein-coupled receptors, as a tool for assessing their localization
and fate in living cells (Sengupta, et al., 1996
; Barak
et al., 1997a
,b
; Tarasova, et al., 1997
; Xiao et al., 1997
). C5aR-GFP functions indistinguishably from
the wild-type C5aR in stably transfected HEK293 cells, where it
mediates chemotaxis over the same range of C5a concentrations (Figure
3). C5aR-GFP functions normally in PLB-985 cells also, at least with
respect to its ability to undergo rapid agonist-induced internalization (Figures 4, 5, 7, and 8), as is the case in other cells for a number of
G protein-coupled receptors fused to GFP (Barak et al., 1997b
; Tarasova, et al., 1997
). Moreover, C5aR-GFP is
targeted to its appropriate location at the plasma membrane of PLB-985 cells, producing a peripheral fluorescent signal that coincides perfectly with that of the fluorescent signal of a plasma membrane probe, DiD (Figures 6 and 7). Finally, it is unlikely that expression of the recombinant C5aR substantially alters sensitivity of PLB-985 cells to C5a ligands, because cell surfaces of these cells display only
60% more C5a-binding sites than do those of control cells expressing
GFP alone (Figure 3).
Behavior of C5aR-GFP Compared with Other Chemoattractant Receptors
Before discussing differences between our findings and those
of others, we should first note that in several respects the C5aR-GFP
fusion protein precisely mimics behavior reported for several other
chemoattractant receptors. To infer behavior of chemoattractant
receptors in living neutrophils, previous investigations used
fluorescently modified ligands, including N-formyl peptides and C5a (Janeczek et al., 1989
; Schmitt and Bultmann, 1990
;
Van Epps, et al., 1990
; Johansson et al., 1993
).
Before receptors are internalized, these fluorescent ligands aggregate
into patches on the neutrophil membrane (Janeczek, et al.,
1989
; Van Epps, et al., 1990
; Johansson, et al.,
1993
); similarly, C5aR-GFP forms clusters at the plasma membrane
shortly after stimulation with C5a (Figure 4C'). After clustering at
the plasma membrane, fluorescent N-formyl peptides are
internalized and accumulate in the uropods of polarized neutrophils
(Schmitt and Bultmann, 1990
); similarly, after plasma membrane clusters
are observed, C5aR-GFP internalizes and accumulates in uropods (Figure
4, F and F'). Finally, fluorescent fMLP ligands accumulated in the
uropods of polarized cells translocate from the uropods to the
perinuclear region of neutrophils (Schmitt and Bultmann, 1990
);
similarly, some internalized C5aR-GFP eventually moves to the
perinuclear region of PLB-985 cells (Figure 5F, cell E, red arrowheads
and our unpublished data). Thus behavior of the C5aR-GFP
molecule closely resembles receptor behavior inferred from studies with
fluorescent ligands.
Our observation that the C5aR remains uniformly distributed on
the surface of neutrophils during chemotaxis is not in accord with
several previous reports that chemoattractant receptors cluster at the
leading edge of neutrophils (Walter and Marasco, 1984
; Schmitt and
Bultmann, 1990
; McKay et al., 1991
) or T lymphocytes (Nieto
et al., 1997
). Unlike our experiments, these investigations either tracked fluorescently tagged ligand (rather than the receptors themselves) in real time or used antibodies or radiolabeled ligands to
detect receptors in fixed cells. Moreover, none of these studies asked
whether the increased fluorescent or radioactive signal at the anterior
pole of a polarized cell represents an increased number of receptor
molecules per unit area of membrane or simply reflects complex membrane
folding at the front. An increased "concentration" of plasma
membrane at the leading edge, probably produced by complex membrane
folds, could produce the illusion of a higher concentration of membrane
receptors, even in confocal microscopy, as suggested by comparing the
C5aR-GFP and DiD patterns of Figures 6 and 7. Instead, our observations
suggest that during chemotaxis C5aR-GFP behaves very like an inert
probe of membrane concentration, and is not concentrated, per unit of
cell surface, at the leading edge or anywhere else. In keeping with
this inference, two studies (McKay et al., 1991
; Nieto
et al., 1997
) showed that the apparent redistribution of
chemoattractant receptors to the leading edge of leukocytes correlated
strictly with the acquisition of a polarized morphology; in one of
these cases (Nieto et al., 1997
), moreover, the
redistribution was observed for receptors other than those whose
activation induced the cell polarization.
Our conclusion that receptors do not accumulate preferentially at the leading edge of migrating neutrophils should be qualified, because of the relatively low resolution of the data. Indeed, some images (e.g., Figure 8) suggest that receptor density may be very much higher on a few membrane projections at the cell's leading edge. These localized increases in receptor density may represent fixation artifact, because they were seen only in images made from fixed cells. Whether or not the increases of C5aR-GFP on membrane projections represent artifacts, we see them in cells responding to fMLP, indicating that they are not agonist specific (our unpublished result).
Possible Mechanisms for Amplifying the Chemotactic Gradient
If receptor redistribution does not amplify the chemotactic gradient, we must conclude that neutrophils use some other mechanism to detect a concentration difference as small as 1% from front to back. How might such an apparent amplification come about? At what level of the signaling pathway does amplification take place? One straightforward possibility is that increased complexity and folding of plasma membrane, which we observed at the leading edge (Figures 6 and 7), increases the sensitivity of the cell's anterior pole simply because the absolute number of receptor molecules is higher there. Tight membrane folds could also induce a significant increase in ratio of cell surface to local volume of cytoplasm (just beneath the membrane); an increase in this ratio would increase the intensity of the cytoplasmic signals (second messengers or activated proteins) that trigger polymerization of actin. Such mechanisms could make the cell sense an apparently steeper gradient of chemoattractant from front to back, reinforcing the cell's polarity and its persistent forward motion.
This scenario cannot be the whole story; however, as indicated by
recent observations, indicating that actin-induced complex folding of
plasma membrane in a pseudopod is not necessary for asymmetric
detection of a chemotactic gradient by D. discoideum cells
(Parent et al., 1998
). In these experiments, a cAMP gradient produced an asymmetric intracellular signal, much greater at the front
than the back, even when actin polymerization was completely blocked by
latrunculin, a toxin that sequesters G-actin. Assessment of the
intracellular signal depended upon ligand-induced recruitment to the
plasma membrane of a GFP-tagged cytoplasmic protein, the cytoplasmic
regulator of adenylyl cyclase (CRAC). After latrunculin treatment, a
cAMP gradient caused no apparent morphological polarity, because actin
was not polymerized; in the same cells, however, the cAMP gradient
caused recruitment of CRAC-GFP to surfaces of the cells facing the
pipette, rather than the side away from the pipette. Thus actin-induced
membrane folds may facilitate directional motility, but are probably
not required for asymmetric detection of a gradient, at least in so far
as neutrophils use detection mechanisms similar to those of D. discoideum.
If this inference applies to the chemotactic-signaling mechanisms of
neutrophils and other eukaryotic cells, it will be necessary to look
for other molecular mechanisms that may amplify asymmetry of the
chemotactic signal. Does amplification of the signal depend upon
asymmetric activity or ligand affinity of receptors, or does it take
place at a downstream site, involving concentrations, recruitment, or
activities of G proteins, RGS (regulators of G protein signaling)
(Dohlman and Thorner, 1997
; Berman and Gilman, 1998
), or effector
molecules? Many scenarios have been suggested (Walter and Marasco,
1987
; Devreotes and Zigmond, 1988
), but none so far is supported by
real evidence. Answers will come from a combination of genetic
analysis, real-time observations of chemotaxis in model systems like
the PLB-985 cell, and biochemical dissection of the signals that link
receptors and G proteins to polymerization of actin.
| |
ACKNOWLEDGMENTS |
|---|
We thank members of the Bourne laboratory for valuable
discussion, and the following individuals for their gifts: A. Abo for the PLB-985 cell line; J.M. Bishop for the
2 packaging cell line and
the pLNCX retroviral vector; J.A. Ember and T.E. Hugli for the
polyclonal anti-C5aR antibody; and C. Gerard for the C5aR cDNA. We also
thank William Hyun and Jane Gordon of the Laboratory for Cell Analysis
for their help with FACS. This work was supported in part by National
Institutes of Health grants GM-27800 and CA-54427 (H.R.B.) and GM-25101
(J.W.S.). G.S. is a Medical Research Council of Canada Postdoctoral
Fellow, and O.D.W. is a Howard Hughes Medical Institute Predoctoral Fellow.
| |
FOOTNOTES |
|---|
Online version of this article contains video
material for Figures 1, 2, 4, and 5. Online version available at
www.molbiolcell.org.
Corresponding author. E-mail address:
h_bourne{at}quickmail.ucsf.edu.
| |
ABBREVIATIONS |
|---|
Abbreviations used: C5aR, C5a receptor; ChaCha, N-Met-Phe-Lys-ProdCha-Cha-dArg; CRAC, cytosolic regulator of adenylyl cyclase; DiD, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate; FACS, fluorescence-activated cell sorting; fMLP, N-formyl-Met-Leu-Phe; GFP, green fluorescent protein; mHBSS, modified HBSS.
| |
REFERENCES |
|---|
|
|
|---|
-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation.
J. Biol. Chem.
272, 27497-27500
2-adrenergic receptor-green fluorescent protein conjugate.
Mol. Pharmacol.
51, 177-184